NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

Approval Number

国药准字S20000011

Company石药集团百克（山东）生物制药股份有限公司

Registration Date

September 30, 2019

Drug Information

Generic Name

重组人粒细胞刺激因子注射液

Trade Name

津恤力

Dosage Form

注射剂

Strength

300μg/支

Drug Type

生物制品

Registration Date

September 30, 2019

Company Information

Applicant Company

Company Name石药集团百克（山东）生物制药股份有限公司

Manufacturing Company

Company Name石药集团百克（山东）生物制药股份有限公司

Company Address

烟台市牟平区沁水韩国工业园金埠大街212号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath